{"name": "TransPharma Medical",
 "permalink": "transpharma-medical",
 "crunchbase_url": "http://www.crunchbase.com/company/transpharma-medical",
 "homepage_url": "http://www.transpharma-medical.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@transpharma.co.il",
 "phone_number": "972-8-9152201",
 "description": "",
 "created_at": "Thu Apr 22 07:33:35 UTC 2010",
 "updated_at": "Thu Apr 22 07:46:54 UTC 2010",
 "overview": "\u003Cp\u003ETransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. Their current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transdermal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0008/4563/84563v1-max-150x150.jpg"],
     [[161,
       49],
      "assets/images/resized/0008/4563/84563v1-max-250x250.jpg"],
     [[161,
       49],
      "assets/images/resized/0008/4563/84563v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$18M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.transpharma-medical.com/press171007.html",
    "source_description": "TransPharma Medical Completes $18 Million Series C Financing ",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 7,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Argonaut Private Equity",
         "permalink": "argonaut-private-equity-3",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pitango Venture Capital",
         "permalink": "pitango-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0001/8978/18978v1-max-150x150.png"],
             [[206,
               73],
              "assets/images/resized/0001/8978/18978v1-max-250x250.png"],
             [[206,
               73],
              "assets/images/resized/0001/8978/18978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Evergreen Venture Partners",
         "permalink": "evergreen-venture-partners",
         "image":
          {"available_sizes":
            [[[133,
               51],
              "assets/images/resized/0003/0648/30648v1-max-150x150.png"],
             [[133,
               51],
              "assets/images/resized/0003/0648/30648v1-max-250x250.png"],
             [[133,
               51],
              "assets/images/resized/0003/0648/30648v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Teva Pharmaceutical Industries",
         "permalink": "teva-pharmaceutical-industries",
         "image":
          {"available_sizes":
            [[[141,
               57],
              "assets/images/resized/0008/4566/84566v1-max-150x150.jpg"],
             [[141,
               57],
              "assets/images/resized/0008/4566/84566v1-max-250x250.jpg"],
             [[141,
               57],
              "assets/images/resized/0008/4566/84566v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "T2C2 Capital",
         "permalink": "t2c2-capital",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0008/4403/84403v1-max-150x150.jpg"],
             [[154,
               54],
              "assets/images/resized/0008/4403/84403v1-max-250x250.jpg"],
             [[154,
               54],
              "assets/images/resized/0008/4403/84403v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Biomedical Investments",
         "permalink": "biomedical-investments",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "TIF Ventures Pte",
         "permalink": "tif-ventures",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2 Yodfat St. ",
    "address2": "Northern Ind. Zone, Lod",
    "zip_code": "71291",
    "city": "",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        124],
       "assets/images/resized/0008/4564/84564v1-max-150x150.jpg"],
      [[250,
        208],
       "assets/images/resized/0008/4564/84564v1-max-250x250.jpg"],
      [[450,
        374],
       "assets/images/resized/0008/4564/84564v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}